Application
Western blot analysis of TNFRSF13B Antibody (N-term) in HL-60 cell line lysates (35ug/lane). TNFRSF13B (arrow) was detected using the purified Pab.Application
TNFRSF13B Antibody (N-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human skin carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the TNFRSF13B Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Product Name | TNFRSF13B Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | TNFRSF13B; TACI; Tumor necrosis factor receptor superfamily member 13B; Transmembrane activator and CAML interactor; CD_antigen=CD267 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | TACI |
|---|---|
| Alternative Names | TNFRSF13B TACI Tumor necrosis factor receptor superfamily member 13B Transmembrane activator and CAML interactor CD_antigen=CD267 |
| Molecular Weight(MW) | 31816 Da |
| Function | Receptor for TNFSF13/APRIL and TNFSF13B/TALL1/BAFF/BLYS that binds both ligands with similar high affinity. Mediates calcineurin-dependent activation of NF-AT, as well as activation of NF-kappa-B and AP-1. Involved in the stimulation of B- and T- cell function and the regulation of humoral immunity |
| Tissue Specificity | Highly expressed in spleen, thymus, small intestine and peripheral blood leukocytes. Expressed in resting B- cells and activated T-cells, but not in resting T-cells |
| Cellular Localization | Membrane; Single-pass type III membrane protein |
| Entrez Gene | 23495 |
|---|
Application
Western blot analysis of TNFRSF13B Antibody (N-term) in HL-60 cell line lysates (35ug/lane). TNFRSF13B (arrow) was detected using the purified Pab.
Application
TNFRSF13B Antibody (N-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human skin carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the TNFRSF13B Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
